Revista Mexicana de Neurociencia (Apr 2023)

Neuropsychiatric and young-onset as clinical determinants for a delayed Huntington’s disease diagnosis

  • Amin Cervantes-Arriaga,
  • David J. García-Romero,
  • Marco Muñuzuri-Camacho,
  • Oscar Esquivel-Zapata,
  • David Dávila-Ortiz de Montellano,
  • Leticia Martínez-Ruano,
  • Ana J. Hernández-Medrano,
  • María A. Ruiz-Mafud,
  • Gloria I. Cerda-Hernández,
  • Arturo Abundes-Corona,
  • Mayela Rodríguez-Violante

DOI
https://doi.org/10.24875/RMN.22000055
Journal volume & issue
Vol. 24, no. 2

Abstract

Read online

Objective: This study aims to identify the possible factors that delay the time-to-diagnosis of Huntington’s disease (HD). Methods: A cross-sectional study in HD patients was carried out. Variables registered were CAG repeats, age of onset, primary symptom at onset, age of molecular diagnosis, and time-to-diagnosis, among others. Results: 107 patients (50.5% female) with a mean age of 49 ± 12.8 years (y) were included in the study. Median CAG size was 45 (38-73). Mean age of onset, mean age of molecular diagnosis, and mean time-to-diagnosis were 39 ± 12.9, 45.1 ± 12.1, and 6.4 ± 6.4 years, respectively. In the comparative analysis, the neuropsychiatric- and the young-onset groups had a longer time-to-diagnosis than the motor- and typical-onset groups (p = 0.02 and p < 0.01, respectively). In the linear regression analysis, neuropsychiatric- and young-onset were independent risk factors. Conclusions: Delayed diagnosis showed relation to neuropsychiatric- and early-onset in HD.

Keywords